Radiculopathy is a painful condition usually due to a compressed nerve in the spine. It is reported that cervical radiculopathy has an annual incidence of 83.2 cases per 100 000 people. Cervical epidural steroid injection is one of the main treatments, but it can result in serious adverse events, including loss of vision, stroke, paralysis, and death.
INTRODUCTION
Radiculopathy is a painful condition usually due to a compressed nerve in the spine. It is characterized by pain, numbness, tingling, or weakness along the course of the nerve. Radiculopathy can occur in any part of the spine, but it is most common in the neck (cervical radiculopathy) and in the lower back. It is reported that cervical radiculopathy has an annual incidence of 83.2 cases per 100 000 people (1). The primary etiology of spinal nerve compression is intervertebral foraminal stenosis associated with cervical spondylosis (70-75%) or herniation of the nucleus pulposus (20-25%). To date, treatment consists of conservative management (e.g., analgesics, cervical collar, cervical traction, physical therapy), interlaminar and transforaminal epidural steroid injections, and surgery (1).
A literature review by Benny et al. classified complications associated with cervical epidural steroid injections into two categories -minor and major (2) . Minor complications are associated with temporary deficits, including vasovagal reactions and transient neurologic deficits, such as pain or weakness, prolonged paresthesias, headaches, hypersensitivity reactions, transient global amnesia, peripheral neuropraxia, and skin rashes (2).
Major complications are considered permanent injuries. Benny et al. reported there are 105 known cases of severe complications, of which only 68 have been well documented (2) . These complications include brain infarction and edema, spinal cord infarction and edema, combined spinal cord and brain infarcts, cortical blindness, high spinal anesthesia, seizures, bleeding, and death. There have been 15 reports of death due to brain and spinal cord infarcts, seizure, high spinal anesthesia, and other unspecified causes (2).
CASE REPORT
A 69-year-old female was admitted to the hospital for the second of three planned C5/C6 epidural steroid injections (each containing 1 mL of 1% bupivacaine, 1 mL of 1% lidocaine, and 40 mg of methylprednisolone). Shortly after the injection, she complained of slurred speech, difficulty breathing, and right-sided weakness. A few hours after the procedure, a "Code Blue" was called and the patient had cardiac arrest after being noted to be hypoxic and not apneic. A computed tomography scan of the head showed a brainstem stroke with hemorrhage. She was on life support and pronounced dead two days later.
A complete autopsy was performed. The positive findings included a needle mark on the lower right side of the neck, extensive hemorrhage and necrosis of the entire right side of the cerebellum and nearby brainstem (Image 1), and extensive petechial hemorrhage of the left side of the cerebellum. The right side of the cerebellum was dusky, soft, and in a near-liquid state (Image 2). There was no hemorrhage in the cerebral hemispheres or cervical spinal cord. She also had early cirrhosis of the liver and atherosclerosis with 70% stenosis of the left anterior descending coronary artery. The cause of death in this case was hemorrhagic infarction of the cerebellum and brainstem due to right cervical epidural steroid injection.
This case was a private autopsy performed in a coroner's office. The policy is to return all organs to the family right after the autopsy, so the brain was not fixed prior to dissection. The entire right side of the cerebellum and nearby brainstem revealed extensive hemorrhage and necrosis; they were not suitable for microscopic study. The cervical spinal cord was dissected and revealed no abnormalities. The vertebral arteries were not evaluated.
DISCUSSION
Multiple types of spinal injections, whether epidural/ translaminar, transforaminal, or facet injections, are offered to patients with or without surgical spinal lesions for pain management. Although not approved by the US Food and Drug Administration (FDA), injections are being performed with increased frequency (160%) (3). Studies suggest they are typically short-acting and ineffective over the long-term and they expose patients to major risks and complications (3). The overall complication rate is about 0-16.8% (4) .
